Compare, Analyse Lupin with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs ACTAVIS (US) - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN   ACTAVIS
EQUITY SHARE DATA
    LUPIN
Mar-20
ACTAVIS
Dec-18
LUPIN/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs88214,145-   
Low Rs5059,488-   
Sales per share (Unadj.) Rs339.43,469.7-  
Earnings per share (Unadj.) Rs-5.9-1,117.6-  
Cash flow per share (Unadj.) Rs15.5365.6-  
Dividends per share (Unadj.) Rs6.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs276.714,311.0-  
Shares outstanding (eoy) m453.00332.60-   
Bonus / Rights / Conversions ESOP--  
Price / Sales ratio x2.03.4 60.0%   
Avg P/E ratio x-116.6-10.6 1,103.1%  
P/CF ratio (eoy) x44.832.3 138.7%  
Price / Book Value ratio x2.50.8 303.5%  
Dividend payout %-100.90-   
Avg Mkt Cap Rs m314,2013,930,206 8.0%   
No. of employees `00018.316.9 108.3%   
Total wages/salary Rs m29,8680-   
Avg. sales/employee Rs Th8,400.668,285.8 12.3%   
Avg. wages/employee Rs Th1,632.00-   
Avg. net profit/employee Rs Th-147.2-21,994.9 0.7%   
INCOME DATA
Net Sales Rs m153,7481,154,030 13.3%  
Other income Rs m4,83822,069 21.9%   
Total revenues Rs m158,5851,176,099 13.5%   
Gross profit Rs m24,84930,241 82.2%  
Depreciation Rs m9,702493,323 2.0%   
Interest Rs m3,63066,594 5.5%   
Profit before tax Rs m16,355-507,606 -3.2%   
Minority Interest Rs m40-   
Prior Period Items Rs m390-   
Extraordinary Inc (Exp) Rs m-7,521129,460 -5.8%   
Tax Rs m11,571-6,433 -179.9%   
Profit after tax Rs m-2,694-371,714 0.7%  
Gross profit margin %16.22.6 616.8%  
Effective tax rate %70.81.3 5,582.9%   
Net profit margin %-1.8-32.2 5.4%  
BALANCE SHEET DATA
Current assets Rs m154,132473,323 32.6%   
Current liabilities Rs m92,252418,717 22.0%   
Net working cap to sales %40.24.7 850.6%  
Current ratio x1.71.1 147.8%  
Inventory Days Days8220 419.1%  
Debtors Days Days12966 195.0%  
Net fixed assets Rs m89,082130,630 68.2%   
Share capital Rs m9060-   
"Free" reserves Rs m124,4610-   
Net worth Rs m125,3674,759,833 2.6%   
Long term debt Rs m17,9331,676,110 1.1%   
Total assets Rs m249,8397,440,703 3.4%  
Interest coverage x5.5-6.6 -83.1%   
Debt to equity ratio x0.10.4 40.6%  
Sales to assets ratio x0.60.2 396.8%   
Return on assets %0.4-4.1 -9.1%  
Return on equity %-2.1-7.8 27.5%  
Return on capital %8.7-4.8 -180.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,9800-   
CASH FLOW
From Operations Rs m14,688412,291 3.6%  
From Investments Rs m11,070226,500 4.9%  
From Financial Activity Rs m-8,906-707,615 1.3%  
Net Cashflow Rs m16,853-68,480 -24.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.1 Rs / USD

Compare LUPIN With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare LUPIN With: NOVARTIS  GSK PHARMA  DISHMAN PHARMA  ABBOTT INDIA  DR. REDDYS LAB  



Today's Market

Sensex, Nifty End at Record Closing High; Tata Steel and Coal India Among Top Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors (Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

Don't Break These 5 Intraday Trading Rules (Fast Profits Daily)

Jun 1, 2021

To become a better intraday trader, follow these rules religiously.

Is the RBI's 'Bubble Talk' Signalling a Market Crash? (Profit Hunter)

May 31, 2021

Is the Indian central bank correct in warning you about a market crash?

Rs 2 Trillion Stimulus Coming to a Stock Market Near You (Profit Hunter)

Jun 2, 2021

Get ready to profit from a massive stimulus that you've never seen before.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

LUPIN SHARE PRICE


Jun 11, 2021 (Close)

TRACK LUPIN

MORE ON LUPIN

LUPIN 5-YR ANALYSIS

COMPARE LUPIN WITH

FEATURED VIDEOS

The 3-Word Secret to Earning Incredible Returns

Buy & Hold v/s In & Out Investing

An Investing System that Found 20 Winners in a Row

Top Pick for Next Decade

More Featured Videos

MARKET STATS